In the wake of grappling with the aftermath of the COVID-19 pandemic, China is now confronting another health emergency, this time among children. A mysterious pneumonia outbreak has surged in Chinese schools, overwhelming hospitals and eliciting serious apprehension from global health experts. Epicenters of the outbreak have been identified in Beijing and Liaoning province, where hospitals are inundated with sick children exhibiting symptoms akin to pneumonia. The severity of the situation has prompted the suspension of classes in certain schools, echoing the early days of the COVID-19 outbreak, as both students and teachers have fallen ill.

According to an analysis undertaken by experts from UCL and the Royal Devon and Exeter Hospital, a change in clinical practice would have clear benefits for patients undergoing major bowel surgery. The study, published in The British Journal of Surgery, shows that administering iron intravenously before colorectal surgery improves patient outcomes by 33 percent, lowering the need for blood transfusions.

Researchers at Indiana University School of Medicine's South Bend regional campus, working with colleagues at the University of Notre Dame, have discovered a new therapeutic target for pulmonary hypertension, a type of high blood pressure that affects the blood vessels in the lungs.

According to a new observational study, anti-rheumatic medicines used to treat rheumatoid arthritis may help reduce the development of autoimmune thyroid disease. The study was published in the Journal of Internal Medicine. Patients with rheumatoid arthritis are more likely to develop autoimmune thyroid illnesses such as Hashimoto's disease and Graves' disease. While immunomodulatory medicines that influence the immune system are commonly used to treat RA patients, they are rarely utilised to treat autoimmune thyroid problems. Instead, thyroid hormone is used to compensate for the abnormalities in normal thyroid function that occur with autoimmune thyroid disease.

Scientists from the Institute of Advanced Study in Science and Technology, Guwahati (IASST), an autonomous institute of North-East India under the Department of Science and Technology (DST), have fabricated a 2D protein monolayer by assembling lysozyme molecules, a model protein in studying diseases like Amyloidosis. Amyloidosis is a rare disease that occurs when a protein called amyloid builds up in organs. This amyloid build-up can affect the working of organs like heart, kidneys, liver, spleen, nervous system and digestive tract.